Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2023-02-17 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings
2023-02-17 English
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings
2023-02-17 English
Loss of Share Certificates
Regulatory Filings
2023-02-16 English
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings
2023-02-16 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of extracts of unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2022. It mentions that these extracts were approved by the Board of Directors and published as newspaper advertisements. The document is short (4197 characters) and primarily serves as a notification of the publication of financial results extracts, not the full financial report itself. It does not contain detailed financial statements or substantive financial data, only an announcement of the publication of financial results extracts. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2023-02-14 English
We would like to inform that pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the extracts of unaudited standalone and consolidated ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of extracts of unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2022. It mentions that these extracts were approved by the Board of Directors and published as newspaper advertisements. The document is short (4197 characters) and primarily serves as a notification of the publication of financial results extracts, not the full financial report itself. It does not contain detailed financial statements or substantive financial data, only an announcement of the publication of financial results extracts. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2023-02-14 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.